052670 — Cheil Bio Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual income statement for Cheil Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	22,986	18,999	16,912	15,349	12,111
Cost of Revenue
Gross Profit	4,877	3,787	2,225	2,445	2,329
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	22,485	19,487	18,639	16,919	14,129
Operating Profit	501	-488	-1,726	-1,570	-2,018
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,496	1,230	138	-1,756	-1,464
Provision for Income Taxes
Net Income After Taxes	2,043	994	-712	-1,708	-1,446
Net Income Before Extraordinary Items
Net Income	2,043	994	-712	-1,708	-1,446
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,043	994	-712	-1,708	-1,446
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	76.9	35.3	-25.2	-60.1	-53.5
Dividends per Share